US Senator Chris Coons was welcomed to DeNovix Inc. to visit the expanded facilities and view the recently patented CellDrop™.
In this post, DeNovix explores primary cell counting using AO/PI with a focus on peripheral blood mononuclear cells (PBMCs).
Viability is a key metric in determining the activity of yeast cells in solution using fluorescent stains like FDA and PI with both cell counters.
Despite the variety of cell counters available, they can typically be divided into one of two sub-groups: manual and automated cell counters.
The Trypan Blue app on CellDrop™ Series instruments enables rapid automated cell counting and viability of cell suspensions stained with Trypan Blue.
DeNovix Inc. announces the award of US Patent 10,302,568 for their innovation in the field of cell counting.
Various methods of cell counting exist for quantifying the total number of cells in solution and calculating sample viability.
DeNovix announces the launch of the CellDrop Automated Cell Counter, the first instrument to remove the need for cell counting slides.